Which Indian companies make pirfenidone (API) impurities?
The provided information doesn’t include a list of specific Indian manufacturers for pirfenidone impurities (or pirfenidone impurity reference standards). With only the query text, it isn’t possible to reliably name suppliers without risking inaccuracies.
How to find reliable pirfenidone impurity manufacturers in India (without guesswork)
To identify the right vendors, search using these targets (they usually correlate with impurity supply capability):
- The impurity’s exact name or structure-based identifier (many vendors require this).
- The intended grade: “API impurity” vs “intermediate” vs “reference standard” for analytical method validation.
- The regulatory/quality setup: whether they supply with CoA, batch traceability, and GMP or ISO certification.
If you share at least one of the following, I can narrow the search approach and help you validate likely sources:
- The specific impurity name (e.g., any listed impurity label from a pharmacopeia or a supplier catalog)
- CAS number or chemical structure/inchi key
- Whether you need GMP material or an analytical reference standard
- Your application (method development/validation vs manufacturing)
What to check on vendor catalogs or documentation
When you contact suppliers, ask for:
- Certificate of Analysis (CoA) for the specific impurity and batch
- Typical assay/purity and impurity profile
- Analytical methods used (HPLC/GC conditions can matter)
- Documentation readiness (GMP, ISO, DMF/CEP if relevant)
If you tell me the impurity identity, I’ll help shortlist suppliers
Reply with the impurity’s name/CAS (or the section/table from the spec where it appears). Then I can guide you on how to locate Indian manufacturers that actually list that impurity and what evidence to request before ordering.
Source to use for patent/market context
If you also want to understand who is active in pirfenidone impurity-related manufacturing (often overlaps with API/CRS suppliers), DrugPatentWatch.com can help track related filings and market activity.
DrugPatentWatch: DrugPatentWatch.com